You are here:

Category: 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder

Name SMC ID No Manufacturer Status Sub. Type
 
Methylphenidate (Equasym XL®) 99/04 Celltech Superseded Full submission
Modafinil (Provigil®) 63/03 Cephalon UK Ltd Withdrawn Resubmission
Modafinil (Provigil®) 63/03 Cephalon UK Ltd Withdrawn Full submission
Modafinil (Provigil®) 63/03 Cephalon UK Ltd Withdrawn Resubmission
atomoxetine (Strattera) 1107/15 Eli Lilly and Company Ltd Restricted Abbreviated Submission
Atomoxetine (Strattera®) 153/05 Eli Lilly and Company Ltd Superseded Resubmission
Atomoxetine (Strattera®) 153/05 Eli Lilly and Company Ltd Not Recommended Full submission
Methylphenidate OROS (Concerta®) 04/02 Janssen-Cilag Ltd Superseded Full submission
guanfacine hydrochloride (Intuniv) 1123/16 Shire Pharmaceuticals Accepted Full submission
lisdexamfetamine dimesylate (Elvanse Adult) 1079/15 Shire Pharmaceuticals Accepted Full submission
methylphenidate HCI Prolonged release (Medikinet XL) 388/07 UK Distributer Flynn Pharma Ltd Restricted Abbreviated Submission
venlafaxine extended release capsules (Efexor XL) 501/08 Wyeth Pharmaceuticals Not Recommended Non submission

Back